M.D., Head of Pathology, Nucleai
Biography
Kenneth J Bloom, MD, FCAP is the Head of Pathology at Nucleai. He brings more than 35 years of clinical experience in pathology, oncology, telemedicine, and bioinformatics. Dr. Bloom has held a myriad of leadership positions including President and Head of Oncology & Immunotherapy for Human Longevity Inc., Chief Medical Officer for In Vitro Diagnostics at GE Healthcare, and Chief Medical Officer of Clarient. Prior to his industry experience, Dr. Bloom spent 15 years at Rush Medical Center holding various appointed positions including Director of Laboratory Operations, Director of Immunohistochemistry and Chief Information Officer of the Rush Cancer Institute. Dr. Bloom has been the principle investigator of more than a dozen clinical trials and has served as an advisor to numerous Pharmaceutical and Bio-Technology Companies. He received M.D. from Rush Medical College and his B.A. from Grinnell College.
Talk
AI and Data Science Showcase:
Nucleai
Nucleai is an AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions by unlocking and analyzing the valuable information in the pathology data.
AI driven spatial biology, the next NGS
AI driven spatial biology will revolutionize our understating of tumor biology.
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S1 - January 25 9.00 A.M.-1.15 P.M.,Showcase Track S1 - January 26 11.30 A.M.-1.15 P.M.,Showcase Track S1 - January 27 11.00 A.M.-1.15 P.M.
The PMWC 2023 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
